ES270748A1 - Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas - Google Patents

Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas

Info

Publication number
ES270748A1
ES270748A1 ES270748A ES270748A ES270748A1 ES 270748 A1 ES270748 A1 ES 270748A1 ES 270748 A ES270748 A ES 270748A ES 270748 A ES270748 A ES 270748A ES 270748 A1 ES270748 A1 ES 270748A1
Authority
ES
Spain
Prior art keywords
substituted
diazines
dihydrobenzo
dioxo
translation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES270748A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Charles Pfizer and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charles Pfizer and Co Inc filed Critical Charles Pfizer and Co Inc
Publication of ES270748A1 publication Critical patent/ES270748A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15Six-membered rings
    • C07D285/16Thiadiazines; Hydrogenated thiadiazines
    • C07D285/181,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/201,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/221,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/241,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/261,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/301,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04DNON-POSITIVE-DISPLACEMENT PUMPS
    • F04D29/00Details, component parts, or accessories
    • F04D29/08Sealings
    • F04D29/10Shaft sealings
    • F04D29/12Shaft sealings using sealing-rings
    • F04D29/126Shaft sealings using sealing-rings especially adapted for liquid pumps
    • F04D29/128Shaft sealings using sealing-rings especially adapted for liquid pumps with special means for adducting cooling or sealing fluid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mechanical Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Structures Of Non-Positive Displacement Pumps (AREA)
ES270748A 1960-09-27 1961-09-26 Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas Expired ES270748A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58632A US3102882A (en) 1960-09-27 1960-09-27 Derivatives of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
GB991/61A GB902658A (en) 1960-09-27 1961-01-10 6-substituted (or unsubstituted) 2-alkyl-3-allylthiomethyl-7-sulphamyl-3,4-dihydrobenzothiadiazine dioxides and process for preparation

Publications (1)

Publication Number Publication Date
ES270748A1 true ES270748A1 (es) 1961-12-16

Family

ID=26236340

Family Applications (1)

Application Number Title Priority Date Filing Date
ES270748A Expired ES270748A1 (es) 1960-09-27 1961-09-26 Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas

Country Status (6)

Country Link
US (1) US3102882A (en, 2012)
BE (1) BE606063A (en, 2012)
DE (2) DE1445121A1 (en, 2012)
ES (1) ES270748A1 (en, 2012)
FR (1) FR1426M (en, 2012)
GB (2) GB902658A (en, 2012)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265573A (en) * 1962-07-27 1966-08-09 Squibb & Sons Inc Benzothiadiazinesulfonamide-1, 1-dioxide composition
US3251837A (en) * 1962-09-14 1966-05-17 Pfizer & Co C Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides
US4338435A (en) * 1981-06-01 1982-07-06 E. R. Squibb & Sons, Inc. Benzothiadiazines having diuretic activity
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
MXPA03006729A (es) 2001-01-26 2003-10-24 Schering Corp Utilizacion de compuestos de azetidinona sustituida para el tratamiento de la sitosterolemia.
SI1413331T1 (sl) 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
ATE345793T1 (de) 2001-09-21 2006-12-15 Schering Corp Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
DE60336485D1 (de) 2002-08-19 2011-05-05 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
EP1560579A1 (en) 2002-11-06 2005-08-10 Schering Corporation Cholesterol absorption inhibitors for the treatment of autoimmune disorders
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
MXPA05009501A (es) 2003-03-07 2005-10-18 Schering Corp Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
DE602004016123D1 (de) 2003-03-07 2008-10-09 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8034782B2 (en) 2008-07-16 2011-10-11 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
DK2170930T3 (da) 2007-06-04 2012-11-05 Synergy Pharmaceuticals Inc Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055B (zh) 2019-01-18 2024-07-23 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Also Published As

Publication number Publication date
DE1445121A1 (de) 1968-11-28
BE606063A (fr) 1962-01-12
GB905137A (en) 1962-09-05
DE1302648B (en, 2012)
US3102882A (en) 1963-09-03
FR1426M (fr) 1962-08-06
GB902658A (en) 1962-08-09

Similar Documents

Publication Publication Date Title
ES270748A1 (es) Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas
ES385635A1 (es) Procedimiento para la preparacion de n-alil-2-arilamino - imidazolinos-(2) sustituidas.
SE7602144L (sv) Kvaternera imidazoliumforeningar
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
ES391633A1 (es) Un procedimiento para la preparacion de una 2,2-diaril-4- piperidinobutiramida.
YU91483A (en) Process for obtaining new thiomethylpyridine derivatives
ES267590A1 (es) Un procedimiento para preparar compuestos quimicos
ES385634A1 (es) Procedimiento para la preparacion de n - cicloalcohil - a- ril - amino - imidazolinas-(2) sustituidas.
US2790806A (en) Heterocyclic compounds and their preparation
ES315051A1 (es) Metodo para la preparaciën de derivados de isoflavonas naturales
ES286931A1 (es) Procedimiento de preparación de nuevos derivados del ácido salicílico
ES274329A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
ES441257A1 (es) Procedimiento para preparar aminocicloles.
Calingaert et al. The Intermetallic Compound Mg4Na4Pb3
ES419142A1 (es) Procedimiento para preparar derivados de tioseudourea.
ES307273A1 (es) Procedimiento para la obtencion de compuestos heterociclicos
ES274332A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano
ES396415A1 (es) Un procedimiento para la preparacion de poliarilimidazolas.
GB1076966A (en) 2-aminoindane derivatives
GR23094B (el) Μεθοδος παρασκευης χημικου προιοντος.
ES350159A1 (es) Procedimiento para la preparacion de derivados de benzodia-cepina.
ES391118A1 (es) Un procedimiento para la preparacion de un nuevo derivado de acido fluoronico.
ES292760A2 (es) Procedimiento de obtención de derivados de 4-aza-tia-xanteno
ES338181A1 (es) Un procedimiento para la preparacion de compuestos dotados de propiedades antibacterianas.
ES240642A1 (es) PROCEDIMIENTO PARA OBTENER NUEVOS COMPUESTOS ORGáNICOS